These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34034377)

  • 21. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
    Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L;
    Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets, the cardiologist, and coronary artery disease: moving beyond aggregation.
    Kleiman NS
    J Am Coll Cardiol; 2004 Jun; 43(11):1989-91. PubMed ID: 15172402
    [No Abstract]   [Full Text] [Related]  

  • 27. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC
    Circulation; 2016 Sep; 134(10):e123-55. PubMed ID: 27026020
    [No Abstract]   [Full Text] [Related]  

  • 28. [Expert consensus on diagnosis and treatment of adult mental stress induced hypertension].
    ;
    Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):716-723. PubMed ID: 34304447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.
    Zhao G; Zhou M; Ma C; Huo Y; Smith SC; Fonarow GC; Ge J; Han Y; Liu J; Hao Y; Liu J; Wang X; Taubert KA; Morgan L; Zhao D; Nie S;
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29602767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in cardiology.
    Menown IA; Shand JA
    Future Cardiol; 2010 Jan; 6(1):11-7. PubMed ID: 20014984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chinese expert consensus on the antiplatelet treatment for patients with stable coronary artery disease].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Feb; 44(2):104-11. PubMed ID: 26926502
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic.
    Nayak D; Aronow WS
    Cardiol Rev; 2005; 13(2):95-7. PubMed ID: 15705260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination antiplatelet therapy: implications for pharmacists.
    Talbert RL; Spinier SA; Nappi JM; Bottorff MB
    J Am Pharm Assoc (Wash); 2002; 42(6):880-3. PubMed ID: 12482014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Building a bridge between cardiologists and surgeons: the consensus document on antiplatelet therapy in patients undergoing surgery after coronary stent implantation].
    Saia F
    G Ital Cardiol (Rome); 2012; 13(7-8):525-7. PubMed ID: 22781381
    [No Abstract]   [Full Text] [Related]  

  • 36. Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
    Collet JP; Roffi M; Byrne RA; Costa F; Valgimigli M; ; ;
    Eur Heart J; 2018 Jan; 39(3):e1-e33. PubMed ID: 29088328
    [No Abstract]   [Full Text] [Related]  

  • 37. Aspirin in coronary artery disease: an appraisal of functions and limitations.
    Würtz M
    Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aspirin use in patients with atherosclerotic cardiovascular disease: the 2016 Chinese expert consensus statement].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):68-80. PubMed ID: 28056332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to letter regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease".
    Fujisue K; Sugiyama S; Ono T; Matsuzawa Y; Akiyama E; Sugamura K; Matsubara J; Kurokawa H; Kaikita K; Iwashita S; Sumida H; Hokimoto S; Oniki K; Nakagawa K; Matsui K; Ogawa H
    Circ Cardiovasc Interv; 2013 Oct; 6(5):e66. PubMed ID: 24129939
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter by Mangiacapra and Barbato regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease".
    Mangiacapra F; Barbato E
    Circ Cardiovasc Interv; 2013 Oct; 6(5):e65. PubMed ID: 24129938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.